格隆汇8月28日丨新凤鸣(603225.SH)发布2025半年度报告，公司上半年实现营业收入334.91亿元，同比 增长7.10%；归母净利润7.09亿元，同比增长17.28%；扣非归母净利润6.60亿元，同比增长22.47%。 ...

格隆汇8月28日丨伯特利(603596.SH)公布半年度报告，2025年1-6月，公司实现营业收入516,380.63万 元，同比增加30.04%；实现归属于上市公司股东的净利润52,233.86万元，同比增加14.19%。报告期 末，公司总资产1,302,581.78万元，较期初增加1.88%。 ...

固高科技公告，2025年上半年营业收入2.45亿元，同比增长16.23%。净利润3090.23万元，同比增长 16.63%。公司计划不派发现金红利，不送红股，不以公积金转增股本。 ...

宏德股份公告，2025年上半年营业收入4.4亿元，同比增长49.11%。净利润2521.71万元，同比增长 34.88%。公司计划不派发现金红利，不送红股，不以公积金转增股本。 ...

绿联科技公告，2025年上半年营业收入38.57亿元，同比增长40.60%。净利润2.75亿元，同比增长 32.74%。公司计划不派发现金红利，不送红股，不以公积金转增股本。 ...

Core Insights - The company reported a revenue of 631 million yuan for the first half of 2025, representing a year-on-year growth of 2.45% [1] - The net profit for the same period was 32.3474 million yuan, showing a year-on-year increase of 9.29% [1] - The company will not distribute profits or increase share capital from capital reserves in the first half of 2025 [1]

Group 1 - The company reported a revenue of 2.038 billion yuan for the first half of 2025, representing a year-on-year increase of 4.46% [1] - The net profit for the same period was 622 million yuan, showing a year-on-year growth of 2.81% [1]

Group 1 - The core viewpoint of the article highlights that Luoyang Molybdenum Co., Ltd. reported a significant increase in net profit for the first half of 2025, reaching 8.671 billion yuan, which represents a year-on-year growth of 60.07%, setting a new historical record for the same period [1] - The company benefited from rising prices of metals such as copper, cobalt, and molybdenum, with gross profit margins for these metals increasing by 1.27, 19.66, and 4.45 percentage points respectively during the first half of the year [1] - Luoyang Molybdenum produced 61,100 tons of cobalt in the first half of the year, generating revenue of 5.728 billion yuan from its cobalt mining operations, which is a year-on-year increase of 31.94% [1]

Core Viewpoint - The company reported significant growth in both sales revenue and net profit for the first half of 2025, indicating a strong operational performance and a solid foundation for achieving annual business goals [1] Financial Performance - The company achieved sales revenue of 1,545.74 million yuan, representing a year-on-year increase of 33.46% [1] - The net profit reached 117.66 million yuan, showing a remarkable year-on-year growth of 100.08% [1] Strategic Initiatives - The company continues to advance its operational strategy focused on "global operations, dual-driven approach, digital intelligence leadership, and efficiency superiority" [1] - The record-high sales revenue in the first half of the year sets a strong foundation for the company's annual operational targets [1]

格隆汇8月27日丨华兰生物(002007.SZ)公告称，公司2025年半年度实现营业收入17.98亿元，同比增长 8.80%；归属于上市公司股东的净利润为5.16亿元，同比增长17.19%。公司拟向全体股东每10股派发现 金红利5元（含税）。 ...